NCT04212988

Brief Summary

Postoperative delirium (POD) is a common complication after cardiac surgery,and the pathogenesis is considered imbalance of cerebral oxygen. It may induce the POD incidence by monitering and intervening the low cerebral oxygen desaturation(SCO2) in cardiac surgery .Near infrared spectroscopy (NIRS) will be used for monitering the cerebral oxygen levels.140 case will be included and divided in to trial and control group. The primary outcome is POD In 72 hours after the surgery , which is assessed according to delirium scale .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 25, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 30, 2019

Completed
2 days until next milestone

Study Start

First participant enrolled

January 1, 2020

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 7, 2022

Completed
Last Updated

April 12, 2022

Status Verified

April 1, 2022

Enrollment Period

2.2 years

First QC Date

December 25, 2019

Last Update Submit

April 10, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • the incidence of POD

    the incidence of postoperative delirium in the cases after 3 days after surgery

    3 days after sugery

Study Arms (2)

the trial group

EXPERIMENTAL

The interwention process will be started once the SCO2 value below ideal levels (80% of the basic level or 50% of absolute value), by adjusting the position of extracorporeal circulation arteriovenous catheter, balancing arterial pressure, increasing oxygen supply , adjusting pump speed ,etc.

Procedure: Increase the SCO2 value

the control group

PLACEBO COMPARATOR

In control group patients, only place the probe for NIRS monitor.

Procedure: Increase the SCO2 value

Interventions

The interwention process will be started once the SCO2 value below ideal levels (80% of the basic level or 50% of absolute value), by adjusting the position of extracorporeal circulation arteriovenous catheter, balancing arterial pressure, increasing oxygen supply , adjusting pump speed ,etc.

the control groupthe trial group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participate and sign the informed consent voluntary;
  • Over 18 years of age;
  • Who recieve the heart surgery under extracorporeal circulation;
  • Able to communicate and abey the experimental requirements well .

You may not qualify if:

  • Refused to sign a consent form;
  • Less than 18 years of age;
  • With history of nervous, mental, and cerebrovascular disease;
  • With history of alcohol or apsychiatric drug addiction;
  • Can't cooperate the evaluation: dementia, dysaudia, visually impaired , etc;
  • Critically diseases: severe liver and kidney dysfunction, cardiac shock or IABP placement status.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

FirstXianJiaotongU

Xi'an, Shaanxi, 710061, China

Location

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: single blind
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 25, 2019

First Posted

December 30, 2019

Study Start

January 1, 2020

Primary Completion

March 31, 2022

Study Completion

April 7, 2022

Last Updated

April 12, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations